Description

Description

Empaphage M (12.5mg/850mg) is a combination oral medication for type 2 diabetes, bringing together the higher strength of Empagliflozin with a mid-range Metformin dose in a single tablet. Each pack contains 14 tablets, offering a treatment option for patients who need a more pronounced level of glucose-excreting support from Empagliflozin alongside a well-established Metformin dose. This particular strength is often reached once a patient has demonstrated good tolerance to lower-dose combinations, or when their doctor determines that stronger dual-action support is needed to achieve better blood sugar control. As with other strengths in this combination range, Empaphage M has also been linked to a reduced risk of cardiovascular death in patients with type 2 diabetes who also have existing heart disease, adding an extra layer of benefit for patients managing both conditions.

Ingredients

Each Empaphage M 12.5mg/850mg tablet contains Empagliflozin at a 12.5mg strength, along with Metformin Hydrochloride at an 850mg strength. Empagliflozin belongs to the SGLT2 inhibitor class of medications, working by reducing glucose reabsorption in the kidneys, which allows excess sugar to be removed from the body through urine rather than remaining in the bloodstream. Metformin, from the biguanide class, works differently, decreasing the amount of glucose produced by the liver, slowing glucose absorption in the gut, and improving how effectively the body’s cells respond to insulin. This combination of strengths offers both a stronger SGLT2-inhibiting effect and a well-established Metformin dose within a single tablet.

Dosage Form

Empaphage M 12.5mg/850mg is supplied as an oral tablet, packaged in a strip format containing 14 tablets, designed for regular use as part of an ongoing diabetes treatment plan.

Uses

Empaphage M 12.5mg/850mg is used, alongside a proper diet and exercise program, to help control high blood sugar levels in adults with type 2 diabetes mellitus, particularly for patients who need a stronger combination of both active ingredients than lower-dose options provide. It is also used to help reduce the risk of death from heart attack, stroke, or heart failure in adults with type 2 diabetes who also have established cardiovascular disease. It is not intended for the treatment of type 1 diabetes. This strength is often used once a patient has been gradually built up through lower-dose therapy, allowing for more substantial blood sugar support once the medication has been well tolerated.

How to Use

Empaphage M 12.5mg/850mg is typically taken with meals, often as part of a twice-daily regimen, to help reduce the digestive side effects associated with the Metformin component. The tablet should be swallowed whole with a glass of water and should never be crushed or chewed. Since this strength often represents a step up from a lower-dose combination, your doctor will likely monitor your response closely during any transition, checking factors such as blood sugar levels, kidney function, and hydration status. It’s important to maintain adequate fluid intake while on this medication, given the increased urination linked to the Empagliflozin component, and to keep meal timing consistent to support stable blood sugar levels throughout the day.

Side Effects

As with other strengths in this combination, Empaphage M 12.5mg/850mg can cause nausea, diarrhea, and abdominal discomfort related to the Metformin component, along with an increased risk of urinary tract infections, genital yeast infections, increased urination, and dehydration linked to the higher Empagliflozin dose. Because this version combines a stronger Empagliflozin dose with a higher Metformin strength, some patients may notice a combination of both digestive and urinary-related effects, particularly during the initial adjustment period. Rarely, too much Metformin can build up in the body and cause lactic acidosis, a serious condition more likely in older adults or those with kidney or liver disease, dehydration, heart failure, or heavy alcohol use, requiring immediate medical attention if symptoms such as unusual tiredness, muscle pain, or difficulty breathing occur. Diabetic ketoacidosis and kidney-related concerns linked to Empagliflozin also call for regular monitoring throughout treatment.

Pregnancy & Breastfeeding

Empaphage M 12.5mg/850mg may be unsafe to use during pregnancy, so it’s important to inform your doctor if you are pregnant or planning to conceive before taking this medication, so they can weigh the potential benefits and risks before determining your treatment approach. Diabetes management during pregnancy typically calls for a different strategy, and your doctor can help identify a more suitable alternative if needed. Breastfeeding mothers should also consult their doctor before using this medication, as its safety during breastfeeding requires individual medical assessment.

Storage Instructions

Store Empaphage M 12.5mg/850mg tablets in a cool, dry place, away from direct sunlight and excess moisture. Keep the tablets in their original packaging until ready for use to help preserve their effectiveness. Store this medication safely out of reach of children and pets, and dispose of any unused or expired tablets responsibly rather than through household waste.

FAQs

Why would a doctor prescribe this combination instead of a lower-dose version? This strength is typically used once a patient has tolerated lower-dose combinations well, providing stronger support from both active ingredients for better blood sugar control.

Will I experience side effects from both components at this dose? Some patients notice a combination of digestive effects from Metformin and urinary-related effects from Empagliflozin, particularly during the early weeks of treatment.

Does this medication support heart health in addition to diabetes control? Yes, this combination has been associated with a reduced risk of cardiovascular death in patients with type 2 diabetes who also have existing heart disease.

How closely will my doctor monitor me on this medication? Your doctor will likely check your blood sugar levels, kidney function, and hydration status regularly, especially if you’ve recently moved up from a lower-dose combination.

Can I switch back to a lower-dose combination if needed? Any change in dosage should only be made under your doctor’s guidance, based on how well you’re tolerating treatment and your overall blood sugar control.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.